Content on Metastatic Triple-Negative Breast Cancer

Race and Metastatic Triple-Negative Breast Cancer

Video
Uncovering the Mystery
Black women have an alarming rate of triple-negative breast cancer, from 15% to 30%, says Demetria Smith-Graziani, MD. Here’s how to address the disparity.
Infographic
Facts About mTNBC Among Black and Hispanic Women
See how triple-negative breast cancer (TNBC) affects Black and Hispanic/Latino people more than other racial and ethnic groups.

Empowering Young Women

A 17-year survivor of triple-negative breast cancer, Maimah Karmo is a warrior. What’s her battle plan to erase disparities and promote survivorship?

Article

Why You Should Know Your Family History

Get the facts on how family history affects your risk of triple-negative breast cancer.

Article

Why Representation Matters in Clinical Trials

Black women are more likely to get metastatic triple-negative breast cancer than other women. But very few Black women participate in research. Learn why that matters.

Video

Barriers to Treatment for Minorities

What factors come into play when treating minorities for this more aggressive type of breast cancer?

Article

Racial Bias and Its Effect on Certain Communities

Learn how discrimination enforced in housing, education, employment, health care, and more may play a role in health disparities.

Article

A Whole-Body Approach

Treatment for metastatic triple-negative breast cancer includes more than cancer drugs. Learn how to care for your whole body when you have mTNBC.

What People are Saying

Slideshow

Tips for Your Journey Through Treatment

Metastatic triple-negative breast cancer has a big impact on your mental and emotional health. Here’s how to thrive – not just survive – during treatment.

Article

Advocating For Yourself

When you have metastatic triple-negative breast cancer, it helps to advocate for yourself. Here’s why and how to go about it.

Video

Disparities in Survivorship

Black women are three times more likely to get triple-negative breast cancer. And they’re often diagnosed at a later stage. Are there barriers to care?